Attention Industry Service Providers!
FREE LIVE WEBINAR • March 05, 2026 • 1:00 PM ET
What Industry Service Providers Need to Know about 340B Orphan Drugs
In 60 minutes, you'll understand the 340B orphan drug rules that govern your covered entity
clients — and why this knowledge is your sharpest competitive edge in the market right now.
Every week, hospitals, health systems, and covered entities across the country are navigating one of the most complex — and most misunderstood — corners of the 340B program.
340B Orphan Drugs.
They operate under a completely separate set of rules from the rest of the 340B program. Most of your clients don't fully understand them. And here's the hard truth:
If you're serving covered entities and you don't understand orphan drugs, you're leaving your clients — and your competitive position — exposed.
$200K+
Average Annual Savings at Risk
90%
of Hospitals Don't Know the Exception
2015
The Rule That Changes Everything
WHAT YOU'LL LEAVE KNOWING:
Why 340B Orphan Drugs are NOT subject to the same rules as the rest of 340B — and what that means for your clients
The 2015 Court Ruling that changed everything for expansion entities — and the gap most service providers are overlooking
How Critical Access Hospitals, RRCs, and Sole Community Hospitals access orphan drug discounts differently than DSH hospitals
What the quarterly orphan drug updates mean for your clients' contracts, systems, and savings potential
The $200,000+ annual savings opportunity your clients may be missing — and how your services can help them capture it
Questions to start asking your covered entity clients to uncover their orphan drug gaps immediately
WHO SHOULD ATTEND:
Account Executives, Consultants, and Client Success teams serving covered entities
340B Software, EMR, and Pharmacy System vendors
Group Purchasing Organizations (GPOs) with hospital clients
Revenue Cycle Management and Reimbursement specialists
Pharmacy Benefit Administrators
Any service provider who wants to go deeper for their hospital clients
YOUR HOST
Dr. Lisa Nezneski, PharmD, BCPS
Founder, 340B Orphan Drug Solutions
40+ years in healthcare. 11+ years focused exclusively on 340B orphan drugs. I've helped expansion entities capture an average of $200,000+ in annual savings by understanding what others miss. Now I'm bringing the Coalition Conference insights directly to you.
Webinar Details:
Date: Thursday, February 19, 2026
Time: 1:00 PM ET
Duration: 60 minutes
Format: Live webinar with Q&A
Cost: FREE
URGENCY ELEMENT: This intelligence is time-sensitive.
The decisions being made NOW will shape 340B for the rest of the year. Don't wait until it's too late to act.
Thursday, March 5, 2026 | 1:00 PM – 2:00 PM Eastern | FREE | Watch for your Demio link after registration.
© 2026 340B Orphan Drug Solutions. All rights reserved.